Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 26, Issue 22, pp. 6039-6050
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 21, 2019
- Revision received July 7, 2020
- Accepted August 17, 2020
- Published first August 20, 2020.
Article Versions
- Previous version (August 20, 2020 - 05:55).
- Previous version (August 25, 2020 - 05:56).
- Previous version (October 6, 2020 - 05:38).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Charles Marusak1,
- Varsha Thakur1,
- Yuan Li1,
- Juliano T. Freitas1,
- Patrick M. Zmina1,
- Vijay S. Thakur2,
- Mayland Chang3,
- Ming Gao3,
- Jiufeng Tan4,
- Min Xiao4,
- Yiling Lu5,
- Gordon B. Mills6,
- Keith Flaherty7,
- Dennie T. Frederick8,
- Benchun Miao8,
- Ryan J. Sullivan8,
- Tabea Moll9,
- Genevieve M. Boland9,
- Meenhard Herlyn4,
- Gao Zhang10, and
- Barbara Bedogni1,*
- 1Department of Dermatology, University of Miami Miller School of Medicine, Miami, Florida.
- 2Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida.
- 3Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana.
- 4The Wistar Institute, Philadelphia, Pennsylvania.
- 5Department of Genomic Medicine, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas.
- 6The Knight Cancer Institute, Oregon Health Sciences University, Portland, Oregon.
- 7Department of Medicine, Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
- 8Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
- 9Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
- 10Department of Neurosurgery, Duke University, Durham, North Carolina.
- ↵*Corresponding Author:
Barbara Bedogni, University of Miami, 1600 NW 10th Ave., RMSB2067, Miami, FL 33136. Phone: 650-387-2993; E-mail: BXB602{at}MIAMI.EDU
November 2020
Volume 26, Issue 22
Volume 26, Issue 22
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
Jump to section
Advertisement